ILKO Pharmaceuticals
ILKO Pharmaceuticals is a privately held Turkish pharmaceutical manufacturer and subsidiary of Selçuklu Holding, producing prescription drugs, consumer health products (Wellcare), medical devices, and biotechnology drugs (İLKOGEN), serving physicians, pharmacies, and patients across Turkey and Balkan export markets.
- Company typePrivate
- Founded2009
- HeadquartersSancaktepe
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What ILKO Pharmaceuticals does
ILKO Pharmaceuticals (İLKO İlaç San. ve Tic. A.Ş.) is a privately held Turkish pharmaceutical manufacturer headquartered in Sancaktepe, Istanbul, with 501-1,000 employees and a subsidiary of the family-owned Selçuklu Holding. The company operates a vertically integrated structure spanning prescription pharmaceuticals (Rx), over-the-counter consumer health products (Wellcare brand), medical devices, high-potency non-sterile products (İLKOPOL subsidiary), and biotechnology drug development (İLKOGEN subsidiary). Its principal manufacturing complex sits on 250,000 m² in Konya's 3rd Organized Industrial Zone, operational since 2012, complemented by a dedicated Çerkezköy facility for high-potency products.
R&D is anchored by two centers: İLKO ARGEM (established 2009 at Hacettepe University Technology Development Zone, 2,600 m²) and İLKO ARGEM Biotechnology Center (established 2015 at Teknopark Istanbul, Turkey's first biotechnology R&D center), which develops recombinant DNA-based biosimilars, bio-betters, and nanobio-betters targeting oncology and immunology. The technology portfolio includes hydrophilic matrix, OROS, MUPS, multi-layer, orally disintegrating tablet (ODT), and topical drug delivery systems.
ILKO monetizes primarily through one-time sales of prescription drugs to physicians via a medical representative field force, distribution of OTC/Wellcare consumer health products through pharmacy retail networks, and emerging direct export channels in the Balkans (Albania, Kosovo, North Macedonia). The company holds comprehensive certifications (GMP, ISO 9001:2015, ISO 13485, ISO 14001, ISO 27001, ISO 50001, OHSAS 18001, Zero Waste) and supports its commercial offering with physician-facing digital platforms Medils, Kontrendike, and Fetal Risk. The Öncel family controls ownership, with Mustafa Öncel (founder) as Honorary President, İsmail Öncel as Chairman, and Hatice Öncel as General Manager.
ILKO Pharmaceuticals firmographics
Firmographics- Name
- ILKO Pharmaceuticals
- Legal name
- İLKO İLAÇ SAN. ve TİC. A.Ş
- Website
- https://ilko.com.tr
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- ILKO Pharmaceuticals is a privately held Turkish pharmaceutical manufacturer and subsidiary of Selçuklu Holding, producing prescription drugs, consumer health products (Wellcare), medical devices, and biotechnology drugs (İLKOGEN), serving physicians, pharmacies, and patients across Turkey and Balkan export markets.
- Ownership category
- akta.pro rank
ILKO Pharmaceuticals industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Immunology & Autoimmune Specialty Pharmaceuticals (HLAIACAB), Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)
Keywords
Where ILKO Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Sancaktepe
Offices4 records
Markets served
ILKO Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Prescription Pharmaceutical Products: Branded generic and innovative pharmaceutical products sold through prescription channel. Includes products across therapeutic areas: cardiovascular, neurological, anti-infective, respiratory, musculoskeletal, and more.
- Consumer Health / OTC Products: Wellcare brand consumer health products including supplements, vitamins, probiotics sold over-the-counter through pharmacy channels.
- Medical Device Products: Medical device products including Sinomarin seawater nasal sprays, Constipass, Gaspass for respiratory and digestive health.
- Biotechnology Products: Biosimilar and innovative biotechnological drugs developed through İLKOGEN for oncology and immunology applications.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
ILKO Pharmaceuticals product offering
Product offeringCore offering
ILKO Pharmaceuticals manufactures prescription pharmaceutical products (Rx) covering cardiovascular, respiratory, neurological, infectious disease, and other therapeutic areas, produces consumer health products (Wellcare brand OTC supplements, probiotics, vitamins), medical devices (Sinomarin nasal sprays, Constipass, Gaspass), and develops biotechnology drugs (İLKOGEN biosimilars). The company operates a 250,000 m² manufacturing complex in Konya, plus two R&D centers — İLKO ARGEM at Hacettepe University Technology Development Zone and İLKO ARGEM Biotechnology Center at Teknopark Istanbul, Turkey's first biotechnology R&D center.
Product overview
İLKO İlaç is a Turkish pharmaceutical company organized as a multi-divisional structure with three core product lines (prescription/Rx drugs, consumer health/OTC products, and medical devices) supported by specialized subsidiaries and digital resources. İLKOPOL handles high-potency non-sterile production; İLKOGEN focuses on biotechnology R&D and biosimilar development; Wellcare serves consumer health needs. Digital platforms Medils, Kontrendike, and Fetal Risk provide medical literature and contraindication information. Two R&D centers (İLKO ARGEM and İLKO ARGEM Biotechnology Center) drive innovation in conventional and biotechnology-based pharmaceuticals.
Differentiator
Problem solved
Functional benefit
Brands
- Wellcare: Consumer health brand providing scientifically-backed health products with 'Art of Living with Health' approach
- İLKOPOL
- İLKOGEN
- Medils
- Kontrendike
- Fetal Risk
Products and services
- Prescription Pharmaceutical Products (Rx) Branded generic and innovative prescription pharmaceutical products covering therapeutic areas including cardiovascular, respiratory, neurology, gastroenterology, endocrinology, dermatology, and infectious diseases. Includes products such as Alecast (montelukast), Valcor (valsartan), Quelept (quetiapine), Regapen (pregabalin), and antibiotics. Sold via medical representative network to doctors and dispensed through pharmacies.
- Wellcare Consumer Health Products (OTC) Over-the-counter consumer health products under the Wellcare brand with 'Art of Living with Health' philosophy. Includes Provim probiotic line, collagen supplements, CoQ10, bromelain, vitamins, and minerals. Distributed through pharmacy networks directly to consumers for preventive health and nutritional supplementation.
- Medical Device Products Medical device products including Sinomarin seawater nasal sprays, Constipass (macrogol) for constipation, Gaspass (simethicone) for digestive health, and other medical devices manufactured under ISO 13485 quality standards.
- İLKOPOL High-Potency Non-Sterile Pharmaceutical Products High-potency non-sterile pharmaceutical products manufactured at a dedicated ISO-certified production facility in Çerkezköy. Quality-assured local production under the İLKOPOL brand.
- İLKOGEN Biotechnology Pharmaceutical Products Turkey's first biotechnology drug research, development, production and international marketing company. Develops biosimilar, bio-better, nano-bio-better, and next-generation biotechnological products using recombinant DNA technology. Focus on oncology and immunology to reduce Turkey's dependence on foreign biotechnological products.
- İLKO ARGEM Pharmaceutical R&D Services Pharmaceutical research and development services at İLKO ARGEM, located in Hacettepe University Technology Development Zone. Conducts analytical, formulation, patent, and clinical research focused on high-value products, specialized drugs, and biological drugs. Capabilities include conventional tablet/capsule, modified release systems, multi-layer tablets, ODT, and topical formulations.
- İLKO ARGEM Biotechnology Center R&D Services Biotechnology research and development services at İLKO ARGEM Biotechnology Center, located at Teknopark Istanbul. Uses recombinant DNA technology to develop biotechnological products for cancer and cancer-related diseases, with work on biosuperior, nanobiosuperior, biosimilar, and next-generation biotech products. Integrated cell-line-to-production infrastructure.
Quantifiable outcome
- Turkey's first biotechnology R&D center
- +2 more outcomes
Companies that use ILKO Pharmaceuticals
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
ILKO Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
ILKO Pharmaceuticals partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered growth, core and minor.
- Business Partners in Albania, Kosovo, and North MacedoniagrowthExternal Markets team conducted strategic visits to business partners in Balkan countries for 2026 and beyond planning. Discussions focused on strengthening portfolio positioning and identifying new product opportunities for regional growth.
- Selçuklu HoldingcoreParent company of İLKO Pharmaceuticals. Selçuklu Holding encompasses İLKO İlaç operations. Onursal başkan (Honorary President) Mustafa Öncel's activities in pharmaceutical sector investments date back to 1960s magistral drug production.
- İLKOPOLcoreSubsidiary brand for high potent non-sterile products manufacturing. Operates as a separate facility in Çerkezköy with ISO-certified quality systems for specialized pharmaceutical production.
- İLKOGENcoreTurkey's first biotechnology drug R&D, production and international marketing company. Focuses on biosimilar development in oncology and immunology to reduce Turkey's dependence on foreign biotechnological products.
- WellcarecoreConsumer health brand bringing scientific and differentiated approach to consumer health field. Focuses on preventive health with 'Art of Living with Health' philosophy.
- Mustafa Öncel FoundationcoreFoundation under Selçuklu Holding conducting education and culture-arts activities. Provides scholarships, supports Mustafa Öncel Primary School, Kamer Öncel Vocational Technical Anatolian High School, and Mustafa Öncel Culture and Sports Complex.
- Tohum Otizm Vakfı (Autism Foundation Turkey)minorSocial responsibility partnerships with autism foundation for inclusive community support.
- TEMA (Turkish Foundation for Combating Soil Erosion)minorEnvironmental sustainability partnership with TEMA for environmental protection activities.
- TURMEPA (Marine Environment Protection Association)minorPartnership for marine environment protection and sustainable water resources.
- Türk Eğitim Vakfı (Turkish Education Foundation)minorEducation support partnership providing scholarships for higher education.
- Hacettepe University Technology Development ZonecoreUniversity-industry collaboration hosting İLKO ARGEM R&D Center since 2009. Located in Hacettepe University campus providing access to academic expertise and research infrastructure.
- Teknopark İstanbulcoreTechnology park hosting İLKO ARGEM Biotechnology Center since 2015. Provides ecosystem for biotech startups and R&D companies.
Scale indicators6 records
Recent moves9 records
Expansion highlights6 records
ILKO Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Krka: Slovenian generic pharmaceutical manufacturer with broad Rx portfolio and strong presence in CEE and Balkan markets. Closely comparable in business model, geography expansion pattern into the Balkans, and product portfolio breadth.
- Ali Raif İlaç: Turkish pharmaceutical manufacturer with branded generics across cardiovascular, CNS, and other therapeutic areas. Comparable mid-tier domestic Rx manufacturer with similar therapeutic breadth.
- Abdi İbrahim: Turkey's largest domestic pharmaceutical manufacturer offering branded generics across multiple therapeutic areas. Highly comparable vertically integrated R&D-to-commercial model serving the same Turkish Rx and OTC channels.
- Eczacıbaşı İlaç (EIP): Turkish pharma division of Eczacıbaşı Group operating in Rx, OTC, and consumer health. Comparable diversified Turkish pharma business model serving doctors, pharmacies, and consumers.
- Mustafa Nevzat İlaç: Turkish pharmaceutical manufacturer (now part of Acino) producing branded generics with strong domestic presence. Comparable in size, therapeutic breadth, and Turkish-market positioning.
- Nobel İlaç: Turkish pharmaceutical company focused on branded generics and consumer health products with strong domestic distribution. Comparable portfolio breadth across Rx and OTC and similar reliance on Turkey's reimbursement system.
- Bilim İlaç: Turkish manufacturer of generic pharmaceuticals with broad therapeutic coverage and in-house R&D. Comparable mid-sized domestic competitor with multi-therapy Rx portfolio and consumer health offerings.
Broad incumbents
- Sandoz: Global leader in generics and biosimilars with extensive footprint in Turkey. Relevant benchmark for İLKOGEN's biosimilar ambitions and a competitor in oncology and immunology categories ILKO is targeting.
- Teva Pharmaceutical Industries: Global generic and specialty pharmaceutical leader with broad portfolio including biosimilars. Relevant competitive benchmark for branded generics and a potential partner or competitor in biosimilar categories.
Emerging players
- Alvotech: Pure-play biosimilar developer focused on immunology and oncology with integrated R&D and manufacturing. Comparable to İLKOGEN's biosimilar pipeline strategy and emerging commercial trajectory in regulated markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks1 record
Key highlights7 records
Customer concentration
ILKO Pharmaceuticals social profiles
Digital presenceILKO Pharmaceuticals compliance and trust
Trust signalCompliance10 records
ILKO Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
ILKO Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles13 records
ILKO Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries8 records
ILKO Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ILKO Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ILKO Pharmaceuticals
What does ILKO Pharmaceuticals do?
ILKO Pharmaceuticals manufactures prescription pharmaceutical products (Rx) covering cardiovascular, respiratory, neurological, infectious disease, and other therapeutic areas, produces consumer health products (Wellcare brand OTC supplements, probiotics, vitamins), medical devices (Sinomarin nasal sprays, Constipass, Gaspass), and develops biotechnology drugs (İLKOGEN biosimilars). The company operates a 250,000 m² manufacturing complex in Konya, plus two R&D centers — İLKO ARGEM at Hacettepe University Technology Development Zone and İLKO ARGEM Biotechnology Center at Teknopark Istanbul, Turkey's first biotechnology R&D center.
Is ILKO Pharmaceuticals a public or private company?
ILKO Pharmaceuticals is a private company. It is classified as family owned and is currently operating.
When was ILKO Pharmaceuticals founded?
ILKO Pharmaceuticals was founded in 2009. It employs 501 to 1,000 people.
Where is ILKO Pharmaceuticals based?
ILKO Pharmaceuticals is headquartered in Sancaktepe.
How does ILKO Pharmaceuticals make money?
Four revenue lines are on record. Prescription Pharmaceutical Products are the primary driver. The others are consumer Health / OTC Products, medical Device Products and biotechnology Products.
Who are ILKO Pharmaceuticals's main competitors?
Direct peers on record are Krka, Ali Raif İlaç, Abdi İbrahim, Eczacıbaşı İlaç (EIP), Mustafa Nevzat İlaç, Nobel İlaç and Bilim İlaç. Broad incumbents are Sandoz and Teva Pharmaceutical Industries. Alvotech is listed as an emerging player.
Does ILKO Pharmaceuticals have an API?
No public API is recorded for ILKO Pharmaceuticals.
What industry is ILKO Pharmaceuticals in?
ILKO Pharmaceuticals's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIACAB, Immunology & Autoimmune Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.